Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open‐label, prospective, observational study

BACKGROUND AND AIMS: Clinical data regarding alendronate jelly are limited. We compared the efficacy and safety of once‐weekly alendronate oral jelly with once‐weekly alendronate tablet formulations in the context of primary osteoporosis. METHODS: In this 6‐month, open‐label, prospective, observatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Okimoto, Nobukazu, Uemura, Yukari, Yoshioka, Toru, Arita, Shinobu, Tsurukami, Hiroshi, Otomo, Hajime, Nishida, Satoshi, Ogawa, Takayuki, Hirao, Ken, Ikeda, Satoshi, Matsumoto, Hidehiro, Toten, Yoriko, Katae, Yuji, Okazaki, Yuichi, Nakagawa, Tsuyoshi, Sakai, Akinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346986/
https://www.ncbi.nlm.nih.gov/pubmed/30697599
http://dx.doi.org/10.1002/hsr2.107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346986/
https://www.ncbi.nlm.nih.gov/pubmed/30697599
http://dx.doi.org/10.1002/hsr2.107

Ejemplares similares